Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1984 1
1987 1
1992 1
1993 3
1995 1
1996 1
1997 2
1998 3
1999 3
2001 4
2002 1
2003 6
2004 6
2005 4
2006 5
2007 3
2008 5
2009 9
2010 8
2011 5
2012 11
2013 18
2014 24
2015 21
2016 17
2017 16
2018 17
2019 25
2020 25
2021 10
2022 18
2023 11
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

266 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %, %, %
The following terms were not found in PubMed: 22Quality, 2Forganization, 5BMAJR
Page 1
1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA).
Ford TJ, Stanley B, Sidik N, Good R, Rocchiccioli P, McEntegart M, Watkins S, Eteiba H, Shaukat A, Lindsay M, Robertson K, Hood S, McGeoch R, McDade R, Yii E, McCartney P, Corcoran D, Collison D, Rush C, Sattar N, McConnachie A, Touyz RM, Oldroyd KG, Berry C. Ford TJ, et al. JACC Cardiovasc Interv. 2020 Jan 13;13(1):33-45. doi: 10.1016/j.jcin.2019.11.001. Epub 2019 Nov 11. JACC Cardiovasc Interv. 2020. PMID: 31709984 Free PMC article. Clinical Trial.

At 1 year, overall angina (Seattle Angina Questionnaire summary score) improved in the intervention group by 27% (difference 13.6 units; 95% confidence interval: 7.3 to 19.9; p < 0.001). Quality of life (EQ-5D index) improved in the intervention group rela

…
At 1 year, overall angina (Seattle Angina Questionnaire summary score) improved in the intervention group by 27% (difference 13.6 uni …
Health-related quality of life with pembrolizumab or placebo plus chemotherapy with or without bevacizumab for persistent, recurrent, or metastatic cervical cancer (KEYNOTE-826): a randomised, double-blind, placebo-controlled, phase 3 trial.
Monk BJ, Tewari KS, Dubot C, Caceres MV, Hasegawa K, Shapira-Frommer R, Salman P, Yañez E, Gümüş M, Hurtado de Mendoza MO, Samouëlian V, Castonguay V, Arkhipov A, Tekin C, Li K, Martin Nguyen A, Monberg MJ, Colombo N, Lorusso D. Monk BJ, et al. Lancet Oncol. 2023 Apr;24(4):392-402. doi: 10.1016/S1470-2045(23)00052-9. Epub 2023 Mar 3. Lancet Oncol. 2023. PMID: 36878237 Clinical Trial.
Patients, investigators, and other study personnel involved in study treatment administration or clinical evaluation of patients were unaware of treatment group assignments. PRO instruments were the EORTC Quality-of-Life-Core 30 (QLQ-C30), the EORTC cervical cancer module …
Patients, investigators, and other study personnel involved in study treatment administration or clinical evaluation of patients were …
Effect of Patient-Centered Transitional Care Services on Clinical Outcomes in Patients Hospitalized for Heart Failure: The PACT-HF Randomized Clinical Trial.
Van Spall HGC, Lee SF, Xie F, Oz UE, Perez R, Mitoff PR, Maingi M, Tjandrawidjaja MC, Heffernan M, Zia MI, Porepa L, Panju M, Thabane L, Graham ID, Haynes RB, Haughton D, Simek KD, Ko DT, Connolly SJ. Van Spall HGC, et al. JAMA. 2019 Feb 26;321(8):753-761. doi: 10.1001/jama.2019.0710. JAMA. 2019. PMID: 30806695 Free PMC article. Clinical Trial.
IMPORTANCE: Health care services that support the hospital-to-home transition can improve outcomes in patients with heart failure (HF). OBJECTIVE: To test the effectiveness of the Patient-Centered Care Transitions in HF transitional care model in patients hospitalized for …
IMPORTANCE: Health care services that support the hospital-to-home transition can improve outcomes in patients with heart failure (HF …
Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non-small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial.
Reck M, Schenker M, Lee KH, Provencio M, Nishio M, Lesniewski-Kmak K, Sangha R, Ahmed S, Raimbourg J, Feeney K, Corre R, Franke FA, Richardet E, Penrod JR, Yuan Y, Nathan FE, Bhagavatheeswaran P, DeRosa M, Taylor F, Lawrance R, Brahmer J. Reck M, et al. Eur J Cancer. 2019 Jul;116:137-147. doi: 10.1016/j.ejca.2019.05.008. Epub 2019 Jun 11. Eur J Cancer. 2019. PMID: 31195357 Free article. Clinical Trial.
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASBI/3-IGI and EQ-5D VAS/UI; with chemotherapy, symptoms and health-related quality of life remained stable (LCSS ASBI/3-IGI, EQ-5D …
During treatment, mean changes from baseline with nivolumab + ipilimumab showed early, clinically meaningful improvements in LCSS ASB …
Infections following left ventricular assist device implantation and 1-year health-related quality of life.
Zhou S, Yang G, Hou H, Zhang M, Grady KL, Chenoweth CE, Aaronson KD, Pienta M, Fetters MD, Paul Chandanabhumma P, Stewart JW 2nd, Cabrera L, Malani PN, Pagani FD, Likosky DS; Michigan Congestive Heart Failure Investigators. Zhou S, et al. J Heart Lung Transplant. 2023 Sep;42(9):1307-1315. doi: 10.1016/j.healun.2023.05.006. Epub 2023 May 13. J Heart Lung Transplant. 2023. PMID: 37187319
BACKGROUND: Left ventricular assist device (LVAD) implantation leads to substantial and sustained improvement in health-related quality of life (HRQOL) among patients. ...The adjusted odds ratio for the primary composite adverse outcome was 1.22 (95% CI, 1.19-1.24, …
BACKGROUND: Left ventricular assist device (LVAD) implantation leads to substantial and sustained improvement in health-related quali …
'Worse than death' and waiting for a joint arthroplasty.
Scott CEH, MacDonald DJ, Howie CR. Scott CEH, et al. Bone Joint J. 2019 Aug;101-B(8):941-950. doi: 10.1302/0301-620X.101B8.BJJ-2019-0116.R1. Bone Joint J. 2019. PMID: 31362549 Free PMC article. Clinical Trial.

AIMS: The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general health questionnaire where an EQ-5D < 0 defines a state 'worse than death' (WTD). ...Multivariate logistic regression was performed. EQ-5D and OHS/OKS were repea

…
AIMS: The EuroQol five-dimension (EQ-5D) questionnaire is a widely used multiattribute general health questionnaire where an EQ-5D …
Health-Related Quality of Life Among Patients With HR+/HER2- Early Breast Cancer.
Criscitiello C, Spurden D, Piercy J, Rider A, Williams R, Mitra D, Wild R, Corsaro M, Kurosky SK, Law EH. Criscitiello C, et al. Clin Ther. 2021 Jul;43(7):1228-1244.e4. doi: 10.1016/j.clinthera.2021.04.020. Epub 2021 Jul 11. Clin Ther. 2021. PMID: 34256965
Of these, 1102 completed the FACT-B and 1083 completed the EQ-5D-5L questionnaires. The mean (SD) FACT-B total score was 99.0 (21.9). ...In addition, mean scores were comparable between the active adjuvant treatment and postadjuvant surveillance groups for the FACT-B total …
Of these, 1102 completed the FACT-B and 1083 completed the EQ-5D-5L questionnaires. The mean (SD) FACT-B total score was 99.0 (21.9). …
Improving Timeliness of Antibiotic Administration Using a Provider and Pharmacist Facing Sepsis Early Warning System in the Emergency Department Setting: A Randomized Controlled Quality Improvement Initiative.
Tarabichi Y, Cheng A, Bar-Shain D, McCrate BM, Reese LH, Emerman C, Siff J, Wang C, Kaelber DC, Watts B, Hecker MT. Tarabichi Y, et al. Crit Care Med. 2022 Mar 1;50(3):418-427. doi: 10.1097/CCM.0000000000005267. Crit Care Med. 2022. PMID: 34415866 Clinical Trial.
We assessed the impact of a pharmacist and provider facing sepsis early warning systems on timeliness of antibiotic administration and sepsis-related clinical outcomes in our setting. DESIGN: A randomized, controlled quality improvement initiative. ...CONCLUSIONS: I …
We assessed the impact of a pharmacist and provider facing sepsis early warning systems on timeliness of antibiotic administration an …
Patient satisfaction with cluneal nerve entrapment surgery.
Kim K, Kokubo R, Isu T, Morimoto D, Morita A. Kim K, et al. Acta Neurochir (Wien). 2022 Oct;164(10):2667-2671. doi: 10.1007/s00701-022-05344-1. Epub 2022 Aug 16. Acta Neurochir (Wien). 2022. PMID: 35972558
The numerical rating scale (NRS) for LBP, the Oswestry Disability Index (ODI) score, and the EuroQOL 5-dimension, 5-level (EQ-5D-5L) scale before and 6 months after the operation were compared. Using these scores, the treatment outcome was compared with the patients' preop …
The numerical rating scale (NRS) for LBP, the Oswestry Disability Index (ODI) score, and the EuroQOL 5-dimension, 5-level (EQ-5D-5L) …
A landscape assessment of the use of patient reported outcome measures in research, quality improvement and clinical care across a healthcare organisation.
Snowdon DA, Srikanth V, Beare R, Marsh L, Parker E, Naude K, Andrew NE. Snowdon DA, et al. BMC Health Serv Res. 2023 Jan 27;23(1):94. doi: 10.1186/s12913-023-09050-1. BMC Health Serv Res. 2023. PMID: 36707827 Free PMC article. Review.
The scope of PROMs was determined by classifying PROMs as either 'specific' to a particular disease and/or condition, or as a 'generic' measure with further classification based on the health domains they measured, using the World Health Organization International Classifi …
The scope of PROMs was determined by classifying PROMs as either 'specific' to a particular disease and/or condition, or as a 'generic' meas …
266 results